Placebo-controlled study of mometasone furoate nasal spray (MFNS) 200 mcg QD in the treatment of seasonal allergic rhinitis
Latest Information Update: 11 Feb 2022
Price :
$35 *
At a glance
- Drugs Mometasone (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Organon
- 04 Mar 2010 Results published in the Journal of Allergy and Clinical Immunology.
- 08 Jun 2007 New trial record.